💨 Abstract
Capricor Therapeutics Inc. reported a second-quarter loss of $25.9 million, or 57 cents per share, falling short of analyst expectations of a 48 cents per share loss. The company's financial performance did not meet Wall Street's projections.
Courtesy: WTOP Staff
Suggested
Schwarber hits his 42nd homer in a 4-run 8th inning as the Phillies rally past the Reds 4-1 -
Republicans, Democrats alike exhort Trump: Keep security pact with Australia and UK alive -
Nevada court apparently clears way for former Raiders coach Jon Gruden to sue NFL over emails -
Publican registros y documentos sobre tiroteo en Uvalde
49ers’ receiving group takes another hit with Jordan Watkins’ injury -
Arkansas authorities say additional employees disciplined at prison where ex-police chief escaped -
Stefanski’s timeline for announcing Browns starting QB remains uncertain -
Correa plays 1st game in Houston since trade as Bregman visits for 1st time since joining Red Sox -
Uvalde school district releases records for 2022 classroom shooting, after legal fight over access -
Empresa: Q2 Earnings Snapshot -